Unknown

Dataset Information

0

The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL.


ABSTRACT: An immune response of appropriate magnitude should be robust enough to control pathogen spread but not simultaneously lead to immunopathology. Primary infection with influenza A virus (IAV) results in a localized pulmonary infection and inflammation and elicits an IAV-specific CD8 T cell immune response necessary for viral clearance. Clearance of IAV-infected cells, and recovery from infection, is mediated by perforin/granzyme B- and Fas/FasL-mediated mechanisms. We recently reported that TRAIL is another means by which IAV-specific CD8 T cells can kill IAV-infected cells. The current study examined the role of TRAIL in the pulmonary CD8 T cell response to a clinically significant IAV [A/PR/8/34 (PR8; H1N1)] infection (i.e., leads to observable, but limited, morbidity and mortality in wild-type [WT] mice). Compared with WT mice, IAV-infected Trail(-/-) mice experienced increased morbidity and mortality despite similar rates of viral clearance from the lungs. The increased morbidity and mortality in Trail(-/-) mice correlated with increased pulmonary pathology and inflammatory chemokine production. Analysis of lung-infiltrating lymphocytes revealed increased numbers of IAV-specific CD8 T cells in infected Trail(-/-) mice, which correlated with increased pulmonary cytotoxic activity and increased pulmonary expression of MIG and MIP-1?. In addition, there was decreased apoptosis and increased proliferation of IAV-specific CD8 T cells in the lungs of Trail(-/-) mice compared with WT mice. Together, these data suggest that TRAIL regulates the magnitude of the IAV-specific CD8 T cell response during a clinically significant IAV infection to decrease the chance for infection-induced immunopathology.

SUBMITTER: Brincks EL 

PROVIDER: S-EPMC3197947 | BioStudies | 2011-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6782110 | BioStudies
2012-01-01 | S-EPMC3466305 | BioStudies
2014-01-01 | S-EPMC4144728 | BioStudies
2020-01-01 | S-EPMC7373319 | BioStudies
2014-01-01 | S-EPMC4100737 | BioStudies
1000-01-01 | S-EPMC4811131 | BioStudies
2018-01-01 | S-EPMC5766251 | BioStudies
2018-01-01 | S-EPMC6109301 | BioStudies
1000-01-01 | S-EPMC4645412 | BioStudies
2017-01-01 | S-EPMC5650162 | BioStudies